ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,569.90
-1.23%
S&P ASX All Technology
2,968.80
-1.53%
Brent Oil
84.82
-1.25%
US Dollar vs AUD
1.54333
-0.05%
Bitcoin
57,148.23
-5.70%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Seagen Inc (SGEN)

  7. Seagen Inc (SGEN) News

SGEN Seagen Inc

228.74
0.00 (0.00%)
Pre Market
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Seagen Inc SGEN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 228.74 10:00:00
Open Price Low Price High Price Close Price Previous Close
228.74
more quote information »

Recent News

Date Time Source Heading
09/1/202422:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
26/12/202322:12EDGAR2Form 15-12G - Securities registration termination [Section..
19/12/202310:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202309:25EDGAR2Form SC 13D/A - General statement of acquisition of..
16/12/202310:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202310:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202309:00PRNUSPADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA®..
15/12/202300:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
15/12/202300:29EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
15/12/202300:00EDGAR2Form 8-K - Current report
15/12/202300:00EDGAR2Form 25-NSE - Notification filed by national security..
13/12/202300:32EDGAR2Form 8-K - Current report
12/12/202323:43DJNPfizer to Close $43 Billion Seagen Acquisition This Week
11/12/202311:30BWADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy..
07/12/202300:15BWTUKYSA® (tucatinib) in Combination with Antibody-Drug..
01/12/202310:04DJNAstellas, Seagen: Cancer Treatment Padcev Supplemental..
01/12/202309:00BWFDA Grants Priority Review for Supplemental Biologics..
14/11/202313:37EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
14/11/202312:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202311:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202310:37EDGAR2Form 144 - Report of proposed sale of securities
10/11/202308:12EDGAR2Form 144 - Report of proposed sale of securities
04/11/202303:00BWSeagen Highlights First Solid Tumor Data for an ADCETRIS®..
03/11/202304:00BWNew Data for ADCETRIS® (brentuximab vedotin) with..
01/11/202323:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202323:09EDGAR2Form 8-K - Current report
01/11/202323:00BWSeagen Third Quarter 2023 Financial Results Reflect Strong..
23/10/202301:30PRNUSGroundbreaking EV-302 Trial Significantly Extends Overall..
20/10/202322:22IHMARKETNEWSFriday’s Wall Street Highlights: SolarEdge, Intuitive..
20/10/202302:14EDGAR2Form 8-K - Current report
16/10/202323:00BWSeagen to Highlight Overall Survival Data for PADCEV® and..
12/10/202323:00BWSeagen to Report Third Quarter 2023 Financial Results on..
23/9/202309:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202309:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202309:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202309:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202309:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202321:02DJNMerck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits..

Your Recent History

NASDAQ
SGEN
Seagen
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved